Recap: Aytu BioPharma Q4 Earnings

Aytu BioPharmaAYTU stock fell by 8.33% on Tuesday after the company reported its Q4 earnings results on Monday, September 27, 2021 at 04:01 PM.

Here's what investors need to know about the announcement.

Aytu BioPharma missed their estimated earnings by 65.31%, which surprised analysts.

Revenue was up $8,621,000 from the same period last year.

Last quarter the company missed on EPS by $-0.12, which was followed by a 3.21% drop in the share price the next day.

Here's a look at Aytu BioPharma's past performance and the resulting price change:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.49	-0.31	-0.44	-0.05	-0.03
EPS Actual	-0.81	-0.43	-0.70	-0.04	-0.02
Price Change %	-8.33%	-3.21%	-1.95%	-5.9%	-12.78%

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Momentum7.28

Growth32.22

Quality-

Value35.78

Short

Medium

Long

Earnings Calendar